Changing epidemiology of an emerging infection: zygomycosis.
Aspergillosis and candidosis remain the most prevalent opportunistic fungal infections in immunocompromised patients, but diseases caused by the Zygomycetes have become of increasing importance. Exposure to antimycotic drugs with no activity against zygomycetes may be a new risk factor and an explanation for the increasing incidence of zygomycosis. The latter infection occurs only rarely in immunocompetent hosts, but in recent years Apophysomyces elegans has been described in many subtropical countries as an emerging pathogen causing mostly cutaneous infections after traumatic inoculation.
Meis
J F
JF
Department of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands. j.meis@cwz.nl
Chakrabarti
A
A
D000935:Antifungal Agents / Q000627:therapeutic use; D021821:Communicable Diseases, Emerging / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D014947:Wounds and Injuries / Q000150:complications; D020096:Zygomycosis / Q000453:epidemiology*
D000935:Antifungal Agents